Zymeworks Inc. (ZYME) stock

ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30141% above fair value

$26.47−2.60 (-8.94%)

Close on Nov 12, 2026Market cap $1.88BP/E 50.9Yield –

Zymeworks operating margin

Operating margin is operating income as a percentage of revenue.

Zymeworks's operating margin for the twelve months ending Sep 30, 2026 was 16.6%. For fiscal 2025 it was -87.3%, against -179.7% the year before. The highest annual figure on record is 31.6% in fiscal 2022.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-87.3%	+92.3
FY2024	Dec 31, 2024	-179.7%	+1.9
FY2023	Dec 31, 2023	-181.6%	−213.3
FY2022	Dec 31, 2022	31.6%	+839.9
FY2021	Dec 31, 2021	-808.2%	−326.9
FY2020	Dec 31, 2020	-481.3%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	69.2%	+149.3
Q2 FY2026	Jun 30, 2026	-919.0%	−917.6
Q1 FY2026	Mar 31, 2026	-1956.7%	−1862.2
Q4 FY2025	Dec 31, 2025	-1755.5%	−1684.0
Q3 FY2025	Sep 30, 2025	-80.1%	+133.7
Q2 FY2025	Jun 30, 2025	-1.4%	+221.5
Q1 FY2025	Mar 31, 2025	-94.5%	+282.4
Q4 FY2024	Dec 31, 2024	-71.6%	+66.8
Q3 FY2024	Sep 30, 2024	-213.8%	−12.4
Q2 FY2024	Jun 30, 2024	-222.9%	+550.0
Q1 FY2024	Mar 31, 2024	-376.9%	−300.2
Q4 FY2023	Dec 31, 2023	-138.4%	−217.7
Q3 FY2023	Sep 30, 2023	-201.4%	+1712.7
Q2 FY2023	Jun 30, 2023	-772.8%	+436.7
Q1 FY2023	Mar 31, 2023	-76.7%	+3717.0
Q4 FY2022	Dec 31, 2022	79.4%	+284.9
Q3 FY2022	Sep 30, 2022	-1914.0%	−526.9
Q2 FY2022	Jun 30, 2022	-1209.5%	–
Q1 FY2022	Mar 31, 2022	-3793.6%	–
Q4 FY2021	Dec 31, 2021	-205.6%	–
Q3 FY2021	Sep 30, 2021	-1387.1%	–